Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesGlomerular and Tubulointerstitial Diseases
You have accessRestricted Access

Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users

Mohammad Bakhriansyah, Patrick C. Souverein, Martijn W.F. van den Hoogen, Anthonius de Boer and Olaf H. Klungel
CJASN September 2019, 14 (9) 1355-1362; DOI: https://doi.org/10.2215/CJN.14331218
Mohammad Bakhriansyah
1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands;
2Medical Faculty, Department of Pharmacology, Lambung Mangkurat University, Banjarmasin, Indonesia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohammad Bakhriansyah
Patrick C. Souverein
1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martijn W.F. van den Hoogen
3Department of Internal Medicine, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthonius de Boer
1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olaf H. Klungel
1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 14 no. 9 1355-1362
DOI 
https://doi.org/10.2215/CJN.14331218
PubMed 
31416888

Published By 
American Society of Nephrology
Print ISSN 
1555-9041
Online ISSN 
1555-905X
History 
  • Received December 7, 2018
  • Accepted June 25, 2019
  • Published online September 6, 2019.

Article Versions

  • Earlier version (August 15, 2019 - 08:08).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2019 by the American Society of Nephrology

Author Information

  1. Mohammad Bakhriansyah1,2,
  2. Patrick C. Souverein1,
  3. Martijn W.F. van den Hoogen3,
  4. Anthonius de Boer1,
  5. Olaf H. Klungel1
  1. 1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands;
  2. 2Medical Faculty, Department of Pharmacology, Lambung Mangkurat University, Banjarmasin, Indonesia; and
  3. 3Department of Internal Medicine, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
  1. Correspondence:
    Dr. Olaf H. Klungel, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Room 3.76, David de Wied Building, Universiteitweg 99, 3584 CG Utrecht, The Netherlands. Email: O.H.Klungel{at}uu.nl
View Abstract

Statistics from Altmetric.com

Article usage

Article usage: August 2019 to December 2020

AbstractFullPdf
Aug 20192537256187
Sep 20191981282218
Oct 2019160014994
Nov 20194473629
Dec 20192692124
Jan 20203054022
Feb 20202142724
Mar 2020149185
Apr 2020132208
May 20201451010
Jun 2020124714
Jul 2020142136
Aug 2020130135
Sep 2020627348
Oct 20204211436
Nov 20204110834
Dec 20202210149

Cited By...

  • 9 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 14 (9)
Clinical Journal of the American Society of Nephrology
Vol. 14, Issue 9
September 06, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users
Mohammad Bakhriansyah, Patrick C. Souverein, Martijn W.F. van den Hoogen, Anthonius de Boer, Olaf H. Klungel
CJASN Sep 2019, 14 (9) 1355-1362; DOI: 10.2215/CJN.14331218

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users
Mohammad Bakhriansyah, Patrick C. Souverein, Martijn W.F. van den Hoogen, Anthonius de Boer, Olaf H. Klungel
CJASN Sep 2019, 14 (9) 1355-1362; DOI: 10.2215/CJN.14331218
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Funding
    • Supplemental Material
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States
  • Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide
  • Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis
Show more Original Articles

Glomerular and Tubulointerstitial Diseases

  • Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy
  • Infection-Related Acute Care Events among Patients with Glomerular Disease
  • Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis
Show more Glomerular and Tubulointerstitial Diseases

Cited By...

  • Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: PRO
  • Management of Drug-Associated Acute Interstitial Nephritis
  • NSAIDs and Nephrotic Syndrome
  • Google Scholar

Similar Articles

Related Articles

  • NSAIDs and Nephrotic Syndrome
  • PubMed
  • Google Scholar

Keywords

  • non-steroidal anti-inflammatory drugs
  • cyclooxygenase selectivity
  • conventional NSAIDs
  • selective COX-2 inhibitors
  • chemical groups
  • nephrotic syndrome
  • pharmacoepidemiology

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire